Advertisement

Physician's First Watch Archive

Medical news from NEJM Journal Watch

December 22, 2014

By Amy Orciari Herman

Edited by André Sofair, MD, MPH

Haruko Obokata, the embattled stem cell researcher whose Nature papers were retracted earlier this year, has resigned after being unable …

By The Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Clinical Practice Center: …

By Amy Orciari Herman

Edited by André Sofair, MD, MPH

The CDC and FDA are investigating a multistate outbreak of listeriosis linked to commercially produced, prepackaged caramel apples. As of Friday, …

December 19, 2014

By Amy Orciari Herman

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

Latanoprost helps maintain visual field function in patients with open-angle glaucoma, according to an industry-supported study in the Lancet. …

By The Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Knowledge+ Blog: What is patient …

By The Editors

The CDC's flu surveillance report in MMWR notes that influenza activity has been increasing in recent weeks:

  • As of Dec. …

By Kristin J. Kelley

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

The FDA has approved fluoroquinolone antimicrobial drops (finafloxacin otic suspension, marketed as …

December 18, 2014

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

Cytisine, a partial agonist of nicotinic acetylcholine receptors, helps smokers quit tobacco more effectively than nicotine-replacement therapy (NRT), according to a New England Journal of …

By Kelly Young

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

Benzodiazepine use in the U.S. is much more common among women …

Pages